Literature DB >> 8288313

Production of an early release, M(r) 36,000 monokine by stimulated rat macrophages.

N M Hedberg1, N Hunter, C Soussou, A E Knop.   

Abstract

Supernatants from rat peritoneal macrophage cultures stimulated with bacterial products contain a M(r) 36,000 factor that protects immature cortical thymocytes from loss of viability over a 4-hr incubation period in vitro. This effect could not be produced with purified transforming growth factor-beta or recombinant interleukin-6 (IL-6). Further, the partially purified M(r) 36,000 fraction was inactive in bioassays for IL-1 and tumour necrosis factor. Maximal production of the factor occurred 2 hr after the addition of 20 micrograms/ml of lipopolysaccharide, as assessed by the titre resulting in 100% protection of thymocytes in a viability assay. The detection of protective activity within 5 min after addition of the stimulant could be attributed to the release of intracellular stores but protein synthesis was required to account for the increasing titre up to peak levels. The titre fell rapidly after 2 hr so that activity could not be detected at 4 hr. This profile of release was refractory to repeated stimulation with lipopolysaccharide. Conjoint addition of lipopolysaccharide and indomethacin, did, however, allow release in response to subsequent challenge. Related to this finding, prostaglandin E2 completely inhibited the release of protective activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288313      PMCID: PMC1422215     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  A rapid method for the separation of large and small thymocytes from rats and mice.

Authors:  J G Salisbury; J M Graham; C A Pasternak
Journal:  J Biochem Biophys Methods       Date:  1979-12

2.  Inhibition of protein synthesis in CHO cells by actinomycin D: lesion occurs after 40S initiation complex formation.

Authors:  N Craig; M Kostura
Journal:  Biochemistry       Date:  1983-12-20       Impact factor: 3.162

3.  Production of lymphocyte activating factor in vivo.

Authors:  P R Wood; L Andrus; I A Clark
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

4.  The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3.

Authors:  D R Haynes; M W Whitehouse; B Vernon-Roberts
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

5.  Thymic reticulum in mice. III. Phagocytic cells of the thymic reticulum in culture secrete both prostaglandin E2 and interleukin 1 which regulate thymocyte proliferation.

Authors:  M Papiernik; F Homo-Delarche
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

6.  Constitutive secretion of interleukin 1 by human monocytes.

Authors:  A J Treves; V Barak; T Tal; Z Fuks
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

7.  Prostaglandin synthesis in different phases of phagocytosis in lung macrophages.

Authors:  W Hsueh; F Gonzalez-Crussi; E Hanneman
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

8.  Co-stimulation of T cell proliferation by transforming growth factor-beta 1.

Authors:  H M Lee; S Rich
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

9.  Evidence for a blood-thymus barrier using electron-opaque tracers.

Authors:  E Raviola; M J Karnovsky
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

10.  DNA replication in mammalian cells. Altered patterns of initiation during inhibition of protein synthesis.

Authors:  R Hand
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more
  1 in total

1.  Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases.

Authors:  Peter L W Yun; Arthur A DeCarlo; Charles Collyer; Neil Hunter
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.